Total Holdings
50
Portfolio diversification across 50 positions
KURE
(NYSEARCA)KraneShares MSCI All China Health Care Index ETF
$17.50-- (--)
Loading... - Market loading
KURE ETF Holdings: KraneShares MSCI All China Health Care Index ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$68.95M
Total fund assets
Expense Ratio
0.65%
Annual management fee
Fund Issuer
KraneShares
NYSEARCA
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 47 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | H HKG:6160 | BeOne Medicines AG | Stock | 9.20% |
| 2 | H HKG:1801 | Innovent Biologics, Inc. | Stock | 8.36% |
| 3 | H HKG:2269 | WuXi Biologics | Stock | 7.61% |
| 4 | S SHA:603259 | WuXi AppTec Co., Ltd. | Stock | 5.90% |
| 5 | S SHG:603259 | WuXi AppTec Co Ltd | Stock | 5.77% |
| 6 | S SHE:300760 | Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A | Stock | 4.52% |
| 7 | S SHG:600276 | Jiangsu Hengrui Medicine Co Ltd | Stock | 4.47% |
| 8 | S SHA:600276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Stock | 4.47% |
| 9 | H HKG:1093 | CSPC Pharmaceutical Group Limited | Stock | 4.00% |
| 10 | H HKG:9926 | Akeso Inc | Stock | 3.95% |
| 11 | H HKG:1177 | Sino Biopharmaceutical Limited | Stock | 3.56% |
| 12 | H HKG:2359 | WuXi AppTec Co., Ltd. | Stock | 3.51% |
| 13 | H HKG:3692 | Hansoh Pharmaceutical Group Company Limited | Stock | 2.84% |
| 14 | S SHA:688271 | Shanghai United Imaging Healthcare Co., Ltd. | Stock | 2.48% |
| 15 | H HKG:1530 | 3SBio Inc. | Stock | 2.46% |
| 16 | S SHE:000538 | Yunnan Baiyao Group Co.,Ltd | Stock | 2.44% |
| 17 | S SHE:300015 | Aier Eye Hospital Group | Stock | 2.12% |
| 18 | S SHG:600436 | Zhangzhou Pientzehuang Pharmaceutical Co Ltd | Stock | 1.95% |
| 19 | S SHA:600436 | Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. | Stock | 1.93% |
| 20 | H HKG:1099 | Sinopharm Group Co. Ltd | Stock | 1.81% |
| 21 | H HKG:6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Stock | 1.75% |
| 22 | S SHE:002422 | Sichuan Kelun Pharmaceutical Co., Ltd. | Stock | 1.61% |
| 23 |  | Legend Biotech Corporation | Stock | 1.52% |
| 24 | S SHA:688506 | Sichuan Biokin Pharmaceutical Co.,Ltd. | Stock | 1.48% |
| 25 | S SHE:000963 | Huadong Medicine Co., Ltd | Stock | 1.37% |
| 26 | S SHG:600196 | Shanghai Fosun Pharmaceutical Group Co Ltd | Stock | 1.28% |
| 27 | S SHA:600196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Stock | 1.27% |
| 28 | H HKG:2268 | WuXi XDC Cayman Inc | Stock | 1.26% |
| 29 | S SHG:601607 | Shanghai Pharmaceuticals Holding Co Ltd | Stock | 1.24% |
| 30 | S SHA:601607 | Shanghai Pharmaceuticals Holding Co., Ltd | Stock | 1.23% |
| 31 | S SHE:002653 | Xizang Haisco Pharmaceutical Group Co Ltd | Stock | 1.15% |
| 32 | S SHE:000999 | China Resources Sanjiu Medical & Pharmaceutical Co Ltd | Stock | 1.11% |
| 33 | H HKG:1548 | Genscript Biotech Corp | Stock | 1.11% |
| 34 | H HKG:0999 | Xiaocaiyuan Intl Hldg Ltd | Stock | 1.03% |
| 35 | S SHE:300255 | Hebei Changshan Biochem Pharma | Stock | 1.01% |
| 36 | S SHG:688578 | Shanghai Allist Pharmaceuticals Co. Ltd. A | Stock | 0.99% |
| 37 | S SHE:002294 | Shenzhen Salubris Pharmaceuticals Co Ltd | Stock | 0.97% |
| 38 | S SHE:300832 | Shenzhen New Industries Biomedical | Stock | 0.94% |
| 39 | S SHG:600085 | Beijing Tongrentang Co Ltd | Stock | 0.93% |
| 40 | S SHE:002252 | Shanghai RAAS Blood Products Co Ltd Class A | Stock | 0.93% |
| 41 | H HKG:2228 | XtalPi Holdings Limited | Stock | 0.91% |
| 42 | S SHE:300122 | Chongqing Zhifei Bio Products | Stock | 0.80% |
| 43 | S SHG:603392 | Beijing Wantai Biological Pharmacy Enterprise Co Ltd | Stock | 0.78% |
| 44 | S SHG:688617 | APT Medical Inc | Stock | 0.76% |
| 45 | S SHE:000661 | Changchun High & New Technology Industries Group Inc | Stock | 0.75% |
| 46 | S SHE:300765 | CSPC Innovation Pharmaceutical Co Ltd Class A | Stock | 0.67% |
| 47 | S SHG:600332 | Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd | Stock | 0.00% |
Frequently Asked Questions About KraneShares MSCI All China Health Care Index ETF Holdings
What are the top holdings in KURE?
KraneShares MSCI All China Health Care Index ETF (KURE) holds 50 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is KURE's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review KURE's holdings table to analyze concentration risk.
What is KURE's sector allocation?
The Sector Allocation chart shows how KURE distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does KURE invest in?
KURE's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is KURE ETF?
KURE's diversification can be assessed by reviewing its 50 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.